Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine randomized-withdrawal study in symptomatic orthostatic hypotension
2012-005760-99Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in orthostatic hypotension (OH) comparing Continued midodrine hydrochloride with Withdrawal to placebo (2 arms). Primary endpoint: Failure to maintain response. Started Mar 2013; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on 2012-005760-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005760-99.